A Aksan

642 total citations
33 papers, 400 citations indexed

About

A Aksan is a scholar working on Hematology, Genetics and Nutrition and Dietetics. According to data from OpenAlex, A Aksan has authored 33 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 10 papers in Genetics and 10 papers in Nutrition and Dietetics. Recurrent topics in A Aksan's work include Iron Metabolism and Disorders (17 papers), Hemoglobinopathies and Related Disorders (10 papers) and Potassium and Related Disorders (7 papers). A Aksan is often cited by papers focused on Iron Metabolism and Disorders (17 papers), Hemoglobinopathies and Related Disorders (10 papers) and Potassium and Related Disorders (7 papers). A Aksan collaborates with scholars based in Germany, Türkiye and Switzerland. A Aksan's co-authors include Jürgen M. Stein, Axel Dignaß, K Farrag, Heinfried H. Radeke, Hatice Işık, Oliver C. Schroeder, Eda Karaismailoğlu, Winfried Häuser, Sıddika Songül Yalçın and Oliver Schröder and has published in prestigious journals such as Gastroenterology, BMJ and Frontiers in Immunology.

In The Last Decade

A Aksan

33 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Aksan Germany 13 195 97 89 65 62 33 400
Ti Shen China 13 119 0.6× 59 0.6× 81 0.9× 15 0.2× 30 0.5× 55 535
Margaret Inman United States 11 46 0.2× 17 0.2× 43 0.5× 37 0.6× 57 0.9× 16 411
M J Gaspar Spain 13 54 0.3× 28 0.3× 64 0.7× 11 0.2× 171 2.8× 34 534
Fahri Uçar Türkiye 12 76 0.4× 36 0.4× 29 0.3× 10 0.2× 17 0.3× 30 318
Léna Le Flem France 10 173 0.9× 24 0.2× 16 0.2× 44 0.7× 16 0.3× 20 779
M Tasso Spain 11 144 0.7× 41 0.4× 24 0.3× 18 0.3× 27 0.4× 23 423
Racha Halawi Lebanon 10 173 0.9× 181 1.9× 15 0.2× 14 0.2× 17 0.3× 14 324
Nagao Shinagawa Japan 9 84 0.4× 57 0.6× 24 0.3× 10 0.2× 54 0.9× 42 331
Rita Maiavacca Italy 13 29 0.1× 30 0.3× 34 0.4× 14 0.2× 53 0.9× 26 340
David Roper United Kingdom 9 191 1.0× 222 2.3× 63 0.7× 18 0.3× 76 1.2× 16 445

Countries citing papers authored by A Aksan

Since Specialization
Citations

This map shows the geographic impact of A Aksan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Aksan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Aksan more than expected).

Fields of papers citing papers by A Aksan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Aksan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Aksan. The network helps show where A Aksan may publish in the future.

Co-authorship network of co-authors of A Aksan

This figure shows the co-authorship network connecting the top 25 collaborators of A Aksan. A scholar is included among the top collaborators of A Aksan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Aksan. A Aksan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakano, Eduardo Yoshio, Cláudia Chaves, Mohammad Rostami‐Nejad, et al.. (2024). From Struggle to Strength: A Multicentric Study on How Public Policies for Celiac Disease Transform Lives. Nutrients. 16(17). 2855–2855. 2 indexed citations
2.
Aksan, A, et al.. (2023). P399 Detection of iron restricted erythropoiesis in patients with IBD: How can we disentangle effects of inflammation?. Journal of Crohn s and Colitis. 17(Supplement_1). i529–i530. 1 indexed citations
4.
Farrag, K, et al.. (2022). P642 Crossroads of vitamin B6 deficiency and inflammation in inflammatory bowel disease: Preliminary results of a cross-sectional study. Journal of Crohn s and Colitis. 16(Supplement_1). i558–i559. 1 indexed citations
7.
Bonn, Florian, et al.. (2022). Relevance of Biotin Deficiency in Patients with Inflammatory Bowel Disease and Utility of Serum 3 Hydroxyisovaleryl Carnitine as a Practical Everyday Marker. Journal of Clinical Medicine. 11(4). 1118–1118. 13 indexed citations
8.
Aksan, A, et al.. (2021). Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK. ClinicoEconomics and Outcomes Research. Volume 13. 541–552. 14 indexed citations
9.
Aksan, A, et al.. (2021). Flipside of the Coin: Iron Deficiency and Colorectal Cancer. Frontiers in Immunology. 12. 635899–635899. 47 indexed citations
10.
Aksan, A, K Farrag, Irina Blumenstein, et al.. (2021). Chronic intestinal failure and short bowel syndrome in Crohn’s disease. World Journal of Gastroenterology. 27(24). 3440–3465. 25 indexed citations
11.
Aksan, A, Alain Schoepfer, Pascal Juillerat, et al.. (2020). Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland. Advances in Therapy. 38(1). 660–677. 15 indexed citations
12.
Farrag, K, A Aksan, Oliver Schröder, & Jürgen M. Stein. (2020). Orale Eisensubstitution (therapie?) bei CED - weniger ist meist mehr?. Zeitschrift für Gastroenterologie. 1 indexed citations
13.
Aksan, A, et al.. (2019). Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 14(3). 316–322. 15 indexed citations
14.
Hausmann, Johannes, et al.. (2019). The role of adipokines in the improvement of diabetic and cardiovascular risk factors within a 52-week weight-loss programme for obesity. Obesity Research & Clinical Practice. 13(5). 440–447. 6 indexed citations
15.
Stein, Jürgen M., et al.. (2018). Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice. Scandinavian Journal of Gastroenterology. 53(9). 1059–1065. 14 indexed citations
16.
Stein, Jürgen M., A Aksan, K Farrag, Axel Dignaß, & Heinfried H. Radeke. (2017). Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice. Expert Opinion on Pharmacotherapy. 18(16). 1721–1737. 23 indexed citations
17.
Aksan, A, Hatice Işık, Heinfried H. Radeke, Axel Dignaß, & Jürgen M. Stein. (2017). Systematic review with network meta‐analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 45(10). 1303–1318. 78 indexed citations
18.
Aksan, A, et al.. (2017). Beslenme ve Diyetetik Eğitiminde Simülasyon Uygulamaları. 2(2). 96–103. 1 indexed citations
19.
Aksan, A, et al.. (2015). MON-PP155: Comparison of Four Nutritional Screening Tools to Assess Malnutrition Risk in Hospitalized Adult Patients. Clinical Nutrition. 34. S185–S186. 1 indexed citations
20.
Aksan, A, et al.. (2015). Validation of the Turkish version of the Celiac Disease Questionnaire (CDQ). Health and Quality of Life Outcomes. 13(1). 82–82. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026